Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.
about
Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in KoreaHLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis).Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody.Clinical and genetic factors predictive of mortality in early systemic sclerosis.Approaches for evaluating rare polymorphisms in genetic association studiesSTAT4 is a genetic risk factor for systemic sclerosis in a Chinese population.Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based studyMajor histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.Apoptosis modulation as a promising target for treatment of systemic sclerosis.Pathogenesis of Systemic Sclerosis.Celiac disease in native Indians from Brazil: A clinical and epidemiological survey.Rheumatic disease among Oklahoma tribal populations: a cross-sectional study.HLA-B35 and dsRNA induce endothelin-1 via activation of ATF4 in human microvascular endothelial cells.Infections are not increased in scleroderma compared to non-inflammatory musculoskeletal disorders prior to disease onset.Clinical and serological features of systemic sclerosis in a Chinese cohort.Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseasesSystematic review of rheumatic disease phenotypes and outcomes in the Indigenous populations of Canada, the USA, Australia and New Zealand.Deciphering the genetic background of systemic sclerosis.Unraveling the genetic component of systemic sclerosis.Increased expression of endoplasmic reticulum stress and unfolded protein response genes in peripheral blood mononuclear cells from patients with limited cutaneous systemic sclerosis and pulmonary arterial hypertension.Dermatology in the North American Indian/Alaska Native population.Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?Causes and consequences of endoplasmic reticulum stress in rheumatic disease.Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada.Systemic Sclerosis is a Complex Disease Associated Mainly with Immune Regulatory and Inflammatory Genes.Tests for the homogeneity of two binomial proportions in extremely unbalanced 2 x 2 contingency tables.Opportunities and challenges in the study of pulmonary arterial hypertension.
P2860
Q28296258-1D2D148C-573B-4D6A-A3CA-3D94C7251BB1Q33855367-DBF9E7AA-A43E-4E6B-95F7-42235D192FBCQ33855883-C93D0687-DCB1-4E14-83FB-1F1CE62A8297Q33903786-311560E3-718D-4853-BEB5-3F817FEFF3DEQ33928089-CB001D05-DE7E-4C9D-A795-FFBF547C0C3EQ33929738-1EBC0127-9190-4787-B738-8EAB0BFD5A42Q34022581-1BF4B78C-0537-4EF8-9A7F-5E80EC69D341Q34046875-AE10688E-7F1D-4E68-B717-61868EC64977Q34385555-FE4D574B-470A-49E4-B1C4-A625CB239863Q35207610-072F9BA6-A433-48E7-BD49-18A3B3670ACDQ35693212-5922C979-52BE-4FE3-B5B2-1D363A656924Q35966511-440669B1-EE55-47BB-9D6E-0A0F460E1B69Q36310765-4EC58789-B18C-4E0C-80B6-EB99E22A4414Q36618485-65DFE473-ED8F-4B8C-8F09-5CB931061F86Q36969186-686948AE-71B9-43DE-9B02-64F2E73E098BQ37073717-C4FFB230-B432-4B3F-B8FE-FC3D1B4735E4Q37438934-99575071-339F-46E0-87BA-6530D14CF79FQ37709963-7435CC9C-5A7F-40FF-BBDB-870557C426DDQ37905783-B9D95ED7-ECB7-47F1-AB2A-D60D9C847EE5Q37973287-6E97405E-8C02-4204-A9EE-FA7F28309060Q38317794-E43AF660-14A0-477F-97E0-DD32459B2CC2Q38609241-9CA75834-087E-4673-BFC0-A2A691C29EA3Q38829051-54EBA200-97E4-4C5E-9417-E35574782C43Q39025066-5A6008BF-988F-4473-B4FD-ADADDB015003Q40001623-0751BBB7-E2BC-4CD0-AE0D-988231985D4EQ41826432-B336DB18-CF6B-4EA7-9149-95F0120B690BQ41948601-126CE4A4-F211-4665-A462-2764E01574DAQ44069499-A8DF843F-1AA2-4938-858C-E86C16016526
P2860
Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype.
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@ast
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@en
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@nl
type
label
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@ast
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@en
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@nl
prefLabel
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@ast
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@en
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@nl
P2093
P356
P1476
Increased prevalence of system ...... h an Amerindian HLA haplotype.
@en
P2093
Cameron HD
Weathers PE
P304
P356
10.1002/ART.1780390814
P577
1996-08-01T00:00:00Z